Antiplatelet agent and uses thereof
OwnerWei-Kung TSENG, Chia-Chun HSU +1inventors
InventorsWei-Kung TSENG, Chia-Chun HSU, Wan-Lin WU
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for suppressing or inhibiting platelet aggregation in a subject in need thereof. The method includes administering to the subject in need thereof an effective amount of Physalin to alleviate or ameliorate symptoms associated with diseases, disorders, and/or conditions resulted from platelet aggregation. According to preferred embodiments, Physalin is applied as a coating on an implantable device, such as a stent or a catheter.
Claims13
1-8. (canceled)
A method for treating a subject having or suspected of having a disease resulting from platelet aggregation comprising administering to the subject an effective amount of physalin for alleviating or ameliorating the symptoms associated with the disease.
20-32. (canceled)
Dependencies are inferred from the claim text.